Francesco Maisano (University Heart Centre, University Hospital Zurich Zurich, Switzerland) works on the border between surgery and interventions; he embraces heart team challenges and...
C Michael Gibson (Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical, Harvard Medical School, Boston, USA) receives “instant gratification” from making a patient...
Vinayak—“Vinnie”—Bapat (New York Presbyterian Hospital/Columbia Medical Center, New York, USA) was all set to become a fighter pilot in the Indian air force until...
Rebecca Hahn (Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, USA) has been at the forefront of the developing field of interventional...
Ran Kornowski (Department of Cardiology, Cardiac Catheterization Laboratories, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel) talks to Cardiovascular News about his career...
Wanting to be like his father, Philip Urban (Cardiovascular Department, Hôpital de la Tour, Geneva, Switzerland) initially considered a career in banking. However, after...
James Blankenship is the 2015-2016 president of SCAI and has been involved with designing and implementing the society's new strategic plan. He talks to Cardiovascular News about the plan and how climbing Kilimanjaro with his three children was a good reminder of what matters most in life.
Alexandra Lansky (Director, Heart and Vascular Clinical Research Program, Yale University School of Medicine, New Haven, USA) talks to Cardiovascular News about what she feels have been the most important clinical breakthroughs in interventional cardiology and what she thinks the next big innovation will be.
Corrado Tamburino (full professor of Cardiology, Ferrarotto & Policlinico Hospitals, University of Catania, Catania, Italy), and a course director for PCR London Valves has done extensive work in developing PCI techniques for left main disease
Javier Escaned (head of Section, Interventional Cardiology Unit, Hospital Clinico San Carlos, Madrid, Spain) is a co-course director of EuroPCR (17-20 May, Paris, France).
Deepak L Bhatt (Executive director of Interventional Cardiovascular Programs, Brigham and Women's Hospital Heart & Vascular Center, Boston, USA) was the co-principal investigator of SYMPLICITY HTN-3, which he believes highlighted the value of sham-controlled trials.
Flavio Ribichini speaks to Cardiovascular News about being involved in the first use of primary angioplasty in Italy and how his belief in the "learning-teaching continuum" informs his clinical practice.
Sunil Rao speaks to Cardiovascular News about his career highlights, including his research into the transradial approach and exploring ways to improve the safety of antithrombotic drugs.
Azeem Latib (senior interventional cardiologist, San Raffaele Hospital and EMO-GVM Centro Cuore Columbus, UniversitÃ Vita Salute, Milan, Italy) started his career in South Africa, relying on the hard work of his mother, numerous weekend jobs, and a community bursary to support his studies, but moved to Italy after meeting his "life-changing" mentor Antonio Colombo.
David J Cohen, director, Cardiovascular Research, Saint Luke's Mid America Heart Institute, Kansas City, USA, has conducted extensive research into the cost-effectiveness of interventional cardiology devices. He talks to Cardiovascular News about his career and why understanding the cost-effectiveness of devices is essential for the future of interventional cardiology.
Ashok Seth is the immediate past president of Cardiological Society of India and is the principal investigator of the Absorb First registry. He has been awarded the "Padma Shri" by the president of India, one of the highest civilian honours of the Government of India, and talks to Cardiovascular News about performing his father's angioplasty, his mission to make Delhi state a safer place to live, and the importance of planning ahead to avoid complications.
Thomas F LÃ¼scher is professor and chairman of Cardiology at the University Heart Center, University Hospital Zurich (Switzerland) and the director of Cardiovascular Research, Institute of Physiology, University of Zurich, Switzerland. He has been involved in many pivotal studies. He spoke to Cardiovascular News about this research and other highlights of his career.
Chaim Lotan is the director of the Heart Institute of The Hadassah-Hebrew University Medical Center (Jerusalem, Israel) and is also course co-director for the Innovations in Cardiovascular Intervention (ICI) meeting (1–3 December, Tel Aviv, Israel). He spoke to Cardiovascular News about his career highlights and the goals of this year's ICI meeting
Morton Kern is chief of cardiology at the Long Beach Veterans Administration Hospital, Long Beach, USA, and is also associate chief of Cardiology at University of California, Irvine, Orange California, USA. He is the co-chair of the Society for Cardiovascular Angiography and Interventions' annual meeting (SCAI; 8–11 May 2013, Orlando, Florida). He talked to Cardiovascular News about his career and his achievements
Stefan D Anker is the 2012–14 president of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). He has been credited with establishing cachexia as an independent prognostic factor for cardiovascular illness, and he has shown that iron deficiency is a valid therapeutic target in heart failure. He spoke to Cardiovascular News about his career, research in heart failure and his goals during his HFA presidency tenure.
David Holmes, past president of the American College of Cardiology, principal investigator of the PROTECT AF trial and other several other studies in electrophysiology and interventional cardiology, spoke to Cardiovascular News about his career, mentors, research and interests outside medicine.
Bernard Chevalier, interventional cardiologist, Cardiovascular Institute Paris-Sud, Jacques Cartier Hospital, Massy, France, talked to Cardiovascular News about his career, current research and innovations in interventional cardiology. He also spoke about a special interest in bioresorbable stent trials and his hobbies, including collecting fine wine.
John Ormiston, Auckland, New Zealand, has investigated important innovations in interventional cardiology such as bioresorbable stents, TAVI and renal denervation. He spoke to Cardiovascular News on these technologies.
Jeffrey Moses, New York, USA, notes that percutaneous aortic valve implantation is probably the most transformative technology in the last 20 years and describes his father's experience of undergoing a TAVI procedure, in this interview with Cardiovascular News. He also spoke about his career, influences, areas of research and his love for skiing and playing tennis.
Ulrich Sigwart, Switzerland, is one of the pioneers in coronary angioplasty, having performed his first case in 1978. He told Cardiovascular News about this first experience, his most memorable cases, and why he considers himself a "nomad".
Martyn Thomas, clinical director of Cardiology and Cardiothoracic Services, St Thomas' Hospital, London, UK, is an enthusiast of transcatheter aortic intervention. In this interview, he told Cardiovascular News why he believes TAVI will be the dominant technology for aortic stenosis within the next 10 years.
Roberto Ferrari, professor of Cardiology at the University of Ferrara, Italy, has recently concluded his term as president of the European Society of Cardiology. He spoke to Cardiovascular News about his current areas of research and his achievements as ESC president.
Ralph Brindis, president of the American College of Cardiology (ACC) 2010–2011, spoke to Cardiovascular News about his career, greatest influences, the National Cardiovascular Registry and his efforts as a swimmer for the University of San Francisco Master's Swim team.
George Dangas, co-director of Transcatheter Cardiovascular Therapeutics (TCT) conference, spoke to Cardiovascular News about his career, research and challenges facing interventional cardiology today.
Josep Brugada speaks to Cardiovascular News about his career, his proudest moments and his association with Barcelona FC.
Alfredo R Galassi, director of diagnostic and cardiovascular interventional laboratory, Ferrarotto Hospital University of Catania, Italy, and associate professor of cardiology, University of Catania, Italy, tells Cardiovascular News International about his career journey to date, and his love of sailing
Silvia G Priori spoke to Cardiovascular News about her career, research, joy in spending time with her two children, and the occasion she took beta-blockers before meeting Dr Mike Rosen.
Cardiovascular News talks to Professor Christian Hamm, Bad Nauheim, Germany, about his influences, current areas of research, and the challenges facing cardiology.
Cardiovascular News talks to Dr Kim Fox, immediate past-president of the European Society of Cardiology (ESC), about getting into cardiology, his interest in ischaemic heart disease and the future of cardiovascular medicine.
(Visited 573 times, 1 visits today)